OpenBilldrug price receipt

NADAC week of 2026-10-14

DEPAKOTE DR 125 MG TABLET

FDA nonproprietary name: divalproex sodium

For 30 tablets

Pharmacies pay

$61.66 filed

30 × $2.05517 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$75.91 estimated

$61.66 + $9.25 (15%) + $5.00 fee per fill = $75.91

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DEPAKOTE DR 125 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as divalproex sodium, under the trade name “Depakote”.

FDA gives its dosage form as tablet, delayed release and its route as oral.

The labeler, the company named on the label, is AbbVie Inc.

FDA lists it under 2 Established Pharmacologic Classes: Anti-epileptic Agent and Mood Stabilizer.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00074-7325-13.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $61.66 for 30 tablets (30 × $2.05517 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.05494 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

11 other products in the NADAC file share the FDA nonproprietary name divalproex sodium with DEPAKOTE DR 125 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
DEPAKOTE DR 125 MG SPRINKLE CP
brand · capsule
$1.96951 per EA filed
eff. 2026-09-23
We don’t know yet
DEPAKOTE DR 125 MG TABLET this page
brand · tablet, delayed release
$2.05517 per EA filed
eff. 2026-09-23
We don’t know yet
DEPAKOTE DR 250 MG TABLET
brand · tablet, delayed release
$4.0456 per EA filed
eff. 2026-09-23
We don’t know yet
DEPAKOTE DR 500 MG TABLET
brand · tablet, delayed release
$7.45557 per EA filed
eff. 2026-09-23
We don’t know yet
DEPAKOTE ER 250 MG TABLET
brand · tablet, extended release
$3.68703 per EA filed
eff. 2026-09-23
$3.66926 per EA filed
Part D 2024 average
DEPAKOTE ER 500 MG TABLET
brand · tablet, extended release
$6.49213 per EA filed
eff. 2026-09-23
$3.66926 per EA filed
Part D 2024 average
DIVALPROEX DR 125 MG CAP SPRNK
generic · capsule, delayed release / capsule, coated pellets
$0.20079 per EA filed
eff. 2026-09-23
We don’t know yet
DIVALPROEX SOD DR 125 MG TAB
generic · tablet, delayed release
$0.05494 per EA filed
eff. 2026-09-23
We don’t know yet
DIVALPROEX SOD DR 250 MG TAB
generic · tablet, delayed release
$0.08564 per EA filed
eff. 2026-09-23
We don’t know yet
DIVALPROEX SOD DR 500 MG TAB
generic · tablet, delayed release
$0.16081 per EA filed
eff. 2026-09-23
We don’t know yet
DIVALPROEX SOD ER 250 MG TAB
generic · tablet, film coated, extended release / tablet, extended release
$0.12984 per EA filed
eff. 2026-09-23
$0.65685 per EA filed
Part D 2024 average
DIVALPROEX SOD ER 500 MG TAB
generic · tablet, film coated, extended release / tablet, extended release
$0.19434 per EA filed
eff. 2026-09-23
$0.65685 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $2.05517 per EA filed.

Of the 85 other products in FDA’s Anti-epileptic Agent class priced per EA, 35 have a higher middle NADAC price and 50 a lower one. The one in the middle is PRIMIDONE 125 MG TABLET, at $1.37851 per EA filed (eff. 2026-09-23).

Of the 72 other products in FDA’s Mood Stabilizer class priced per EA, 26 have a higher middle NADAC price and 46 a lower one. The one in the middle is LAMOTRIGINE ER 300 MG TABLET, at $1.25965 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.